The global aloe vera market is anticipated to grow at a considerable CAGR of 7.5% during the forecast period. The aloe vera plant has been used for thousands of years to heal a variety of conditions, most notably burns, wounds, skin irritations, and constipation. It contains numerous vitamins and minerals, enzymes, amino acids, natural sugars, and agents which are...

Gastrointestinal (GI) infections are common problems which are resolved rapidly but aggravate in certain healthcare settings. There are recorded cases of 3-6 million children dying due to gastroenteritis worldwide. Gastrointestinal agents are recommended by doctors and clinicians to alleviate problems caused in lupus, gastroesophageal reflux disease (GERD), and others. Market Research Future...

The global anal fistula therapeutics market is estimated to grow at a CAGR of nearly 4.0% during the forecast period. Rising incidences of inflammatory bowel disease (IBD) is the major factor encouraging the demand for anal fistula therapeutics. As per the Centers for Disease Control and Prevention (CDC), in 2015, nearly 1.3% of the US adults (3 million) were reported being diagnosed with IBD...

The Biosimilars of Infliximab Market report provides detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global Biosimilars of Infliximab Market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic...

Market Research Future (MRFR) analysed the Global Capsule Endoscopy Market Research 2023 through the analysis period till 2030. As per MRFR assessment, the capsule endoscopy market is expected to rise at 8.4% CAGR in the review period. BY 2030, the capsule endoscopy market is anticipated to touch USD 1.29 Bn. COVID 19 impact study for the capsule endoscopy market is supplemented with thee...

Market Research Future (MRFR) analysed the Global Capsule Endoscopy Market 2024 through the analysis period till 2032. As per MRFR assessment, the capsule endoscopy market is expected to rise at 8.4% CAGR in the review period. BY 2032, the capsule endoscopy market is anticipated to touch USD 1.6 Bn, driven by advancements in medical imaging technology and a growing preference for...

The global Crohn’s disease drugs market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to accelerate the growth of the market include the increasing incidence of inflammatory bowel syndrome, such as Crohn’s disease and ulcerative colitis. This Crohn’s Disease Drugs Market research report focuses more on a number of...

The Crohn’s Disease market size was valued at USD 11.1 billion in 2022 and is projected to grow from USD 11.5 Billion in 2023 to USD 15.37 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.7% during the forecast period (2023 - 2032). Crohn's disease is a type of inflammatory bowel disease (IBD), caused by a combination of environmental, immune, and bacterial factors in...

Crohn’s Disease Market Highlights: The Crohn’s Disease market size was valued at USD 11.1 billion in 2022 and is projected to grow from USD 11.5 Billion in 2023 to USD 15.37 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.7% during the forecast period (2023 - 2032). Crohn's disease is a type of inflammatory bowel disease (IBD), caused by a combination of...

The global Crohn’s disease market is estimated to grow at a significant CAGR of 4.2% during the forecast period. Crohn's disease inflammation spreads into the layers of affected bowel tissues. Crohn's disease is painful and may lead to life-threatening complications. Anti-inflammatory drugs, immune system suppressors, antibiotics, anti-diarrheal medications, pain relievers, iron...